Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

JAML promotes CD8 and γδ T cell antitumor immunity and is a novel target for cancer immunotherapy

The Journal of Experimental Medicine(2021)10.1084/jem.20202644Source: DataRank Database

JAML promotes CD8 and γδ T cell antitumor immunity and is a novel target for cancer immunotherapy is a research paper published in The Journal of Experimental Medicine (2021). On theSindex it has a DataRank of 0. It has been cited 32 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access32 citations

Download PDF

Cite:

Linked data & code

geo

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)OA: hybridTopics (36)IDs (PubMed, PMC)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (7)

Flavian Thelen ORCID,Eric Hampton ORCID,Nelson E. Bruno ORCID,Travis S. Young ORCID,Wendy L. Havran ORCID

Live enrichment

PubMed:34427588 PMC:PMC8404475

National Institutes of Health

Grant: AI064811

NIAID NIH HHS

Grant: R01 AI064811

National Institutes of Health

Grant: 4R01AI064811-10

JAML: A New Costimulatory Molecule for Gamma Delta T Cells

Skaggs Graduate School of Chemical and Biological Sciences, Scripps Research Institute

hybridLicense: CC BY NC SA

Europe_PMChttps://europepmc.org/articles/PMC8404475

Europe_PMChttps://europepmc.org/articles/PMC8404475?pdf=render

https://doi.org/10.1084/jem.20202644

https://pubmed.ncbi.nlm.nih.gov/34427588

http://dx.doi.org/10.1084/jem.20202644

Fields of Study

0301 basic medicine0303 health sciences03 medical and health sciences

MeSH Terms

T-Lymphocyte SubsetsCD8-Positive T-LymphocytesAnimalsMice, Inbred C57BLMice, KnockoutHumansMiceNeoplasmsMelanomaMelanoma, ExperimentalCell Adhesion MoleculesReceptors, Antigen, T-Cell, gamma-deltaImmunotherapyGene Expression Regulation, NeoplasticCoxsackie and Adenovirus Receptor-Like Membrane ProteinImmune Checkpoint Inhibitors

Keywords

Mice, KnockoutCoxsackie and Adenovirus Receptor-Like Membrane ProteinMelanoma, ExperimentalReceptors, Antigen, T-Cell, gamma-deltaCD8-Positive T-LymphocytesArticleGene Expression Regulation, NeoplasticMice, Inbred C57BLMiceT-Lymphocyte SubsetsNeoplasmsAnimalsHumansImmunotherapyCell Adhesion MoleculesImmune Checkpoint InhibitorsMelanoma

Sustainable Development Goals

SDG 3: 3. Good health

JAML promotes CD8 and γδ T cell antitumor immunity and is a novel target for cancer immunotherapy

FAIR Checklist

Authors (7)

Funding (4 grants)

Open Access

Topics

Annotations (Europe PMC)